Fr | De
Keine Artikel ausgewählt!     Warenkorb  
Sie sind hier: Fachliteratursuche zu Eisenmangel » Bei Niereninsuffizienz 29. Mai 2015
Suchen
Eisenplattform
Bei Niereninsuffizienz
Erweiterte Suche
Update Eisenmangel
Praxishilfen/Tipps
Fachliteratursuche zu Eisenmangel
Bei Frauen
Bei chronischer Magen-Darm-Erkrankung
Bei Niereninsuffizienz
Bei onkologischen Patienten
Bei Herzinsuffizienz
News
FAQ
Veranstaltungen
Für Experten
  Schrift: Schrift grösser Schrift kleiner

   Seite 1 von 139  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 2766  
   
The Labile Side of Iron Supplementation in CKD.
J Am Soc Nephrol.
Slotki I, Cabantchik ZI.
PMID: 25999405 [PubMed - as supplied by publisher]


Relationship between hepcidin and GDF15 in anemic patients with type 2 diabetes without overt renal impairment.
Diabetes Res Clin Pract.
Hong JH, Choi YK, Min BK, Park KS, Seong K, Lee IK, Kim JG.
PMID: 25998917 [PubMed - as supplied by publisher]


Renal functional and structural integrity in infants with iron deficiency anemia: relation to oxidative stress and response to iron therapy.
Pediatr Nephrol.
El-Shimi MS, El-Farrash RA, Ismail EA, El-Safty A, Nada AS, El-Gamel OA, Salem YM, Shoukry SM.
PMID: 25980471 [PubMed - as supplied by publisher]


Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.
PLoS One.
Connor JR, Zhang X, Nixon AM, Webb B, Perno JR.
PMID: 25973894 [PubMed - in process]


Heme iron polypeptide for the management of anaemia of chronic kidney disease.
J Clin Pharm Ther.
Dull RB, Davis E.
PMID: 25953602 [PubMed - as supplied by publisher]


Ask about ice, then consider iron.
J Am Assoc Nurse Pract.
Rabel A, Leitman SF, Miller JL.
PMID: 25943566 [PubMed - as supplied by publisher]


Switching patients with non-dialysis chronic kidney disease from oral iron to intravenous ferric carboxymaltose: effects on erythropoiesis-stimulating agent requirements, costs, hemoglobin and iron status.
PLoS One.
Toblli JE, Di Gennaro F.
PMID: 25928811 [PubMed - in process]


A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients.
Nephrol Dial Transplant.
Bhandari S, Kalra PA, Kothari J, Ambühl PM, Christensen JH, Essaian AM, Thomsen LL, Macdougall IC, Coyne DW.
PMID: 25925701 [PubMed - as supplied by publisher]


Anemia management and mortality risk in newly visiting patients with chronic kidney disease in Japan: The CKD-ROUTE study.
Nephrology (Carlton).
Iimori S, Naito S, Noda Y, Nishida H, Kihira H, Yui N, Okado T, Sasaki S, Uchida S, Rai T.
PMID: 25917812 [PubMed - as supplied by publisher]


Newly diagnosed anemia in admitted diabetics, frequency, etiology and associated factors.
J Coll Physicians Surg Pak.
Shams N, Osmani MH.
PMID: 25899186 [PubMed - in process]


Role of preoperative intravenous iron therapy to correct anemia before major surgery: study protocol for systematic review and meta-analysis.
Syst Rev.
Elhenawy AM, Meyer SR, Bagshaw SM, MacArthur RG, Carroll LJ.
PMID: 25874460 [PubMed - in process]


Iron-hepcidin dysmetabolism, anemia and renal hypoxia, inflammation and fibrosis in the remnant kidney rat model.
PLoS One.
Garrido P, Ribeiro S, Fernandes J, Vala H, Bronze-da-Rocha E, Rocha-Pereira P, Belo L, Costa E, Santos-Silva A, Reis F.
PMID: 25867633 [PubMed - in process]


A new machine learning approach for predicting the response to anemia treatment in a large cohort of End Stage Renal Disease patients undergoing dialysis.
Comput Biol Med.
Barbieri C, Mari F, Stopper A, Gatti E, Escandell-Montero P, Martínez-Martínez JM, Martín-Guerrero JD.
PMID: 25864164 [PubMed - in process]


Hepcidin in chronic kidney disease: not an anaemia management tool, but promising as a cardiovascular biomarker.
Neth J Med.
van der Weerd NC, Grooteman MP, Nubà MJ, Ter Wee PM, Swinkels DW, Gaillard CA.
PMID: 25852110 [PubMed - in process]


Alcohol dependence and physical comorbidity: Increased prevalence but reduced relevance of individual comorbidities for hospital-based mortality during a 12.5-year observation period in general hospital admissions in urban North-West England.
Eur Psychiatry.
Schoepf D, Heun R.
PMID: 25841661 [PubMed - as supplied by publisher]


Iron supplementation associates with low mortality in pre-dialyzed advanced chronic kidney disease patients receiving erythropoiesis-stimulating agents: a nationwide database analysis.
Nephrol Dial Transplant.
Kuo KL, Hung SC, Liu JS, Chang YK, Hsu CC, Tarng C.
PMID: 25829323 [PubMed - as supplied by publisher]


Triggers, inhibitors, mechanisms, and significance of eryptosis: the suicidal erythrocyte death.
Biomed Res Int.
Lang E, Lang F.
PMID: 25821808 [PubMed - in process]


Iron-based phosphate binders: do they offer advantages over currently available phosphate binders?
Clin Kidney J.
Negri AL, Ureña Torres PA.
PMID: 25815172 [PubMed]


Is anemia a new cardiovascular risk factor?
Int J Cardiol.
Kaiafa G, Kanellos I, Savopoulos C, Kakaletsis N, Giannakoulas G, Hatzitolios AI.
PMID: 25814357 [PubMed - as supplied by publisher]


Risk of cancer in patients with iron deficiency anemia: a nationwide population-based study.
PLoS One.
Hung N, Shen CC, Hu YW, Hu LY, Yeh CM, Teng CJ, Kuan AS, Chen SC, Chen TJ, Liu CJ.
PMID: 25781632 [PubMed - in process]


   
   Artikel 1 - 20 / 2766    Seite 1 von 139  vorhergehende Seite nächste Seite

 
 

  Zeitfenster  
   

Ein Expertenteam bürgt für Aktualität und Qualität. Mitglieder sind:

 

- Prof. W.A. Wuillemin

  Luzern

- Prof. D. Surbek

  Bern

- PD Dr. B. Favrat

  Lausanne

 

Informationen für Ihre Patienten

check-dein-eisen.ch >>

 

 

Save the date

 

8. Iron Academy 

2015

Lugano, Lausanne, Zürich

mehr >>

Illustration: Eisen im Körper

Literatursuche andere Fachgebiete

Fachliteratur auf medline.ch screenen und gleich online bestellen

mehr >>